Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia

Biochemistry, Genetics and Molecular Biology

• Brain Circulation 50%
• Bromodeoxyuridine 50%
• Cell Cycle 50%
• Cell Death 100%
• Cell Proliferation 50%
• DNA Microarray 50%
• Downregulation 100%
• Gene Expression 100%
• Magnesium Sulfate 100%
• Motor Activity 50%
• Oxygenation 50%
• Reelin 100%

Neuroscience

• Brain Injury 50%
• Bromodeoxyuridine 50%
• Cell Cycle 50%
• Cell Death 100%
• Cell Proliferation 50%
• DNA Microarray 50%
• Gene Expression 100%
• Ischemia 50%
• Learning Disabilities 50%
• Magnesium Sulfate 100%
• Reelin 100%
• Stereotypic Movement Disorder 50%

Keyphrases

• 5 Gene 9%
• Brain Circulation 9%
• Brain Oxygenation 9%
• Bromodeoxyuridine 9%
• Cell Cycle Genes 9%
• Cell Death 18%
• Cell Proliferation 9%
• Delayed Response 9%
• DNA Microarray Analysis 9%
• Expression Change 9%
• Fetal Hypoxia 9%
• Gene number 9%
• Gene Response 100%
• Gene Set 27%
• Gestational Week 9%
• Granule Layer 9%
• Human Infants 9%
• Hypoxia 54%
• Hypoxia Response 100%
• Hypoxia-ischemia 9%
• Induced Damage 9%
• Induced Minor 9%
• Learning Disabilities 9%
• Magnesium Sulfate 100%
• Maternal Hypoxia 27%
• Mild Hypoxia 9%
• Motor Impairment 9%
• Murine Model 9%
• Neurodevelopmental Abnormalities 9%
• Perinatal Brain Damage 9%
• Pretreatment Effect 9%
• Reelin 9%
• Reelin Signaling 9%
• Seizure Activity 9%
• Severe Cases 9%
• Sulfur Treatment 100%
• Transcriptional Response 9%